Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

CureLab Oncology is a biotechnology company that is developing new anti-cancer biologics.CureLab Oncology is committed to creating a family of revolutionary therapies for oncology patients in order to help prolong their lives.Our lead product, Elenagen, is a plasmid (supercoiled circular DNA) encoding gene p62/SQSTM1. Elenagen reverses tumor grade, changes tumor microenvironment, enhances the anti-cancer effects of other the...
CureLab Oncology is a biotechnology company that is developing new anti-cancer biologics.CureLab Oncology is committed to creating a family of revolutionary therapies for oncology patients in order to help prolong their lives.Our lead product, Elenagen, is a plasmid (supercoiled circular DNA) encoding gene p62/SQSTM1. Elenagen reverses tumor grade, changes tumor microenvironment, enhances the anti-cancer effects of other therapies (e.g. chemotherapy), mitigates chronic inflammation, and stimulates an immune attack on the tumor.

List your booth number for exhibitions, ask us